7A40 - Central Sleep Apneas: Complete Coding and Diagnostic Guide

1. Introduction

Central Sleep Apneas represent a group of sleep-related respiratory disorders characterized by reduction or cessation of airflow due to diminished or absent respiratory effort. Unlike obstructive apnea, where there is physical obstruction of the airways, in central apnea the problem resides in the neurological control of respiration, resulting in respiratory pauses that can significantly compromise sleep quality and blood oxygenation.

The clinical importance of central sleep apneas is substantial, although it is less prevalent than obstructive apnea. This disorder predominantly affects patients with congestive heart failure, users of opioid medications, individuals at high altitudes, and those with specific neurological conditions. The exact prevalence varies according to the population studied, being particularly common in cardiac patients, where it may affect a significant proportion of cases.

The impact on public health is considerable, as central apneas are associated with greater cardiovascular morbidity and mortality, sleep fragmentation, daytime fatigue, cognitive impairment, and reduced quality of life. Patients who are undiagnosed or inadequately treated present increased risk of cardiovascular events, arrhythmias, and deterioration of cardiac function.

Correct coding using ICD-11 code 7A40 is critical for multiple reasons: it enables appropriate epidemiological tracking, facilitates health resource planning, ensures appropriate reimbursement of diagnostic and therapeutic procedures, enables comparative clinical research, and assures continuity of care among different professionals and institutions. Accurate documentation is also fundamental to justify specific treatments such as non-invasive ventilation devices and specialized follow-up.

2. Correct ICD-11 Code

Code: 7A40

Description: Central sleep apneas

Parent category: Sleep-related breathing disorders

Official definition: Central Sleep Apneas are characterized by reduction or cessation of airflow due to reduced or absent respiratory effort. Central Apnea (cessation of airflow) or hypopnea (reduction of airflow) may occur in a cyclic or intermittent manner. Patients with central sleep apnea of various etiologies may also exhibit obstructive events, in which case a diagnosis of both central sleep apnea and obstructive sleep apnea may be given.

A fundamental aspect of this classification is the recognition that many patients present mixed patterns of respiratory events during sleep. The presence of obstructive events does not exclude the diagnosis of central apnea when it is predominant or clinically significant. This approach allows for more precise characterization of the pathophysiology of sleep-related breathing disorder in each patient.

Important note: A definitive diagnosis requires objective evidence based on polysomnography. This examination is considered the gold standard for documenting respiratory events, differentiating them between central and obstructive, quantifying their frequency, and evaluating their impact on sleep architecture and oxygenation. Polysomnography simultaneously records multiple parameters including airflow, thoracic and abdominal respiratory effort, oxygen saturation, brain activity, eye movements, and muscle tone, allowing for precise characterization of apneic events.

3. When to Use This Code

Code 7A40 should be used in specific clinical scenarios where polysomnographic documentation confirms the presence of central apneas or hypopneas as a predominant or clinically significant pattern:

Scenario 1: Patient with heart failure and Cheyne-Stokes respiration A patient with congestive heart failure presents with complaints of fragmented sleep, nocturnal awakenings, and daytime fatigue. Polysomnography reveals a cyclic pattern of central apneas with characteristic crescendo-decrescendo respiration (Cheyne-Stokes), with apnea-hypopnea index (AHI) predominantly central greater than 5 events per hour. In this case, code 7A40 is appropriate, documenting central apnea related to cardiac disease.

Scenario 2: Chronic opioid medication use A patient undergoing prolonged treatment with opioids for chronic pain develops excessive daytime somnolence and reports of respiratory pauses observed by their partner. Polysomnography demonstrates multiple central apneas and ataxic breathing patterns, with absence of respiratory effort during events. Central AHI is greater than obstructive AHI. Code 7A40 is indicated to document opioid-induced central apnea.

Scenario 3: Idiopathic central apnea An individual without significant comorbidities, not a user of respiratory depressant medications, presents with sleep fragmentation and fatigue. Polysomnography reveals recurrent central apneas without Cheyne-Stokes pattern, without identifiable secondary cause. After exclusion of other etiologies, code 7A40 is used for primary or idiopathic central apnea.

Scenario 4: Central apnea at high altitudes A person who resides or frequently travels to high-altitude regions develops sleep disorders with frequent awakenings. Polysomnography performed at altitude demonstrates periodic respiration with recurrent central apneas related to hypobaric hypoxia. Code 7A40 appropriately documents this condition.

Scenario 5: Treatment-emergent central apnea A patient initially diagnosed with obstructive sleep apnea initiates continuous positive airway pressure (CPAP) therapy. During follow-up, the patient experiences persistence of symptoms and new polysomnography with CPAP reveals suppression of obstructive events, but development of significant central apneas. This condition, known as treatment-emergent central apnea, is coded with 7A40.

Scenario 6: Neurological conditions with impaired respiratory control A patient with previous stroke or neurodegenerative disease presents with sleep disorders. Polysomnography demonstrates central apneas related to impairment of cerebral respiratory centers. Code 7A40 is appropriate when central apnea is the predominant manifestation.

4. When NOT to Use This Code

It is fundamental to recognize situations where code 7A40 is not appropriate, avoiding coding errors that may compromise proper care and documentation:

Neonatal central apnea: When the patient is a newborn presenting with central apneas related to immaturity of the central nervous system or perinatal conditions, the appropriate code is 252052617 (Neonatal central apnea), not 7A40. This distinction is crucial because the pathophysiology, diagnostic approach, and treatment differ significantly between neonates and adults.

Predominantly obstructive apnea: When polysomnography reveals that the majority of respiratory events are obstructive (presence of respiratory effort during pauses), even if there are some occasional central events, the correct code is 7A41 (Obstructive sleep apnea). The predominance of the obstructive pattern determines the primary coding.

Hypoventilation without clear central apneas: Patients with sleep-related hypoventilation (sustained elevation of CO2 during sleep) without discrete central apneic events should be coded with 7A42 (Sleep-related hypoxia or hypoventilation disorders), not 7A40.

Respiratory pauses during wakefulness: Events of apnea or respiratory pause that occur exclusively during wakefulness, without relation to sleep, should not be coded as 7A40. These conditions require investigation of other causes, such as anxiety disorders, hyperventilation, or neuromuscular conditions.

Absence of polysomnographic confirmation: Clinical diagnosis of central apnea without objective confirmation by polysomnography does not justify the use of code 7A40, as specified in the official definition. In these cases, codes for symptoms or suspected diagnosis may be more appropriate until the confirmatory test is performed.

5. Step-by-Step Coding Process

Step 1: Assess diagnostic criteria

Confirmation of central sleep apnea diagnosis requires systematic evaluation that includes:

Initial clinical evaluation: Detailed collection of clinical history focusing on sleep quality, daytime somnolence, nocturnal awakenings, observation of respiratory pauses, fatigue, cognitive impairment, and relevant comorbidities (heart failure, neurological conditions, medication use). Physical examination to identify contributing factors.

Diagnostic polysomnography: Mandatory examination that must document: presence of apneas (cessation of airflow for at least 10 seconds) or hypopneas (reduction of airflow associated with desaturation or arousal) with absence of thoracic and abdominal respiratory effort during events; calculation of total apnea-hypopnea index (AHI) and specific index for central events; assessment of oxygen saturation; documentation of sleep architecture and fragmentation.

Quantitative criteria: Generally, a central AHI equal to or greater than 5 events per hour is considered significant, although interpretation should consider clinical context and presence of symptoms.

Step 2: Verify specifiers

Complete coding should consider:

Severity: Based on AHI - mild (5-15 events/hour), moderate (15-30 events/hour), or severe (above 30 events/hour). Severity influences therapeutic decisions and prognosis.

Respiratory pattern: Identify whether there is Cheyne-Stokes pattern (periodic crescendo-decrescendo breathing), irregular ataxic breathing, or central apneas without specific pattern.

Etiology: Document whether central apnea is idiopathic, related to heart failure, medication-induced (especially opioids), altitude-related, treatment-emergent, or associated with neurological conditions.

Presence of mixed events: Document whether there are also significant obstructive events, which may justify dual coding.

Step 3: Differentiate from other codes

7A41 - Obstructive sleep apnea: The fundamental difference lies in the presence of respiratory effort. In obstructive apnea, there is persistent or increased thoracic and abdominal effort during respiratory pauses, indicating upper airway obstruction. In central apnea (7A40), there is absence or diminution of respiratory effort, reflecting failure in neural command of respiration. Polysomnography clearly differentiates these patterns through respiratory effort sensors.

7A42 - Sleep-related hypoxia or hypoventilation disorders: This category includes conditions where there is sustained reduction in ventilation with elevated CO2 (hypoventilation) or oxygen desaturation, but without discrete and recurrent central apneic events. Examples include hypoventilation related to obesity, neuromuscular diseases, or chest wall alterations. If the patient presents primarily with sustained hypoventilation without episodic central apneas, 7A42 is more appropriate than 7A40.

Step 4: Required documentation

Checklist of mandatory information:

• Complete polysomnography report with discrimination between central and obstructive events
• Total AHI and specific central AHI
• Minimum oxygen saturation and time with saturation below 90%
• Description of respiratory pattern (Cheyne-Stokes, ataxic, etc.)
• Relevant comorbidities (heart failure, neurological conditions)
• Medications in use, especially opioids or sedatives
• Clinical symptoms (daytime somnolence, sleep quality, fatigue)
• Previous treatments for sleep disorders, if applicable

Adequate documentation: Documentation must clearly specify "central sleep apnea" with reference to ICD-11 code 7A40, include quantitative polysomnography data, and describe etiology when identifiable. This complete documentation facilitates continuity of care, justifies specific treatments, and allows adequate audit.

6. Complete Practical Example

Clinical Case

A 62-year-old male patient presents to a sleep medicine clinic reporting progressive daytime fatigue over the last 8 months, frequent nocturnal awakenings, and a sensation of non-restorative sleep. His wife reports observing respiratory pauses during sleep, followed by deeper breathing.

Medical history: Congestive heart failure diagnosed 3 years ago, currently in functional class II, with ejection fraction of 35%. Currently on optimized cardiac medications. Denies use of opioids or sedatives. Body mass index of 27 kg/m², neck circumference of 39 cm. No significant nasal obstruction or anatomical alterations of the upper airway on physical examination.

Initial evaluation: Epworth Sleepiness Scale score of 14 (moderate to significant daytime sleepiness). Denies intense snoring or nocturnal choking episodes. Reports need to urinate 2-3 times per night.

Diagnostic polysomnography: Complete overnight polysomnography was performed, which revealed:

• Total sleep time: 6.2 hours
• Sleep efficiency: 72% (moderate fragmentation)
• Total AHI: 32 events per hour
• Central AHI: 28 events per hour
• Obstructive AHI: 4 events per hour
• Respiratory pattern: Characteristic Cheyne-Stokes with cycles of 45-60 seconds
• Minimum oxygen saturation: 84%
• Time with saturation below 90%: 18% of total sleep time
• Sleep architecture: reduction in deep sleep and REM

Diagnostic reasoning: The patient presents with moderate to severe sleep apnea (AHI 32/hour) with a clear predominance of central events (28 central events versus 4 obstructive). The Cheyne-Stokes respiratory pattern is characteristic and is directly related to the underlying congestive heart failure. The presence of some obstructive events (4/hour) does not alter the primary diagnosis, as central apnea is clearly predominant and clinically significant.

Coding justification: Code 7A40 is appropriate because: (1) there is objective confirmation by polysomnography; (2) central events predominate widely; (3) there is characteristic Cheyne-Stokes pattern; (4) the etiology (heart failure) is consistent with central apnea; (5) the clinical symptoms are compatible.

Step-by-Step Coding

Criteria analysis:

• Polysomnographic criterion: ✓ (central AHI 28/hour, well above the 5/hour threshold)
• Absence of respiratory effort: ✓ (confirmed by thoracic and abdominal sensors)
• Clinical symptoms: ✓ (fatigue, fragmented sleep, nocturnal awakenings)
• Impact on oxygenation: ✓ (desaturation to 84%, 18% of time below 90%)

Code selected: 7A40 - Central sleep apneas

Complete justification: Coding with 7A40 is fully justified by objective polysomnographic documentation demonstrating predominance of central events (87.5% of events are central), characteristic Cheyne-Stokes respiratory pattern of central apnea related to heart failure, presence of clinically significant symptoms, and impact on nocturnal oxygenation. Although occasional obstructive events exist (4/hour), these are minority events and do not alter the primary diagnosis.

Applicable complementary codes:

• Code for congestive heart failure (underlying etiological condition)
• Code for nocturnal desaturation, if coding system allows additional specification
• Possibly code 7A41 as secondary diagnosis if there is a need to document the presence of an obstructive component, although minority

Therapeutic plan resulting from this coding: Based on this coding, treatment will include optimization of cardiac therapy, consideration of adaptive servo-ventilation (specific for central apnea with Cheyne-Stokes), and joint follow-up with cardiology. Conventional CPAP would not be the first choice in this case.

7. Related Codes and Differentiation

Within the Same Category

7A41: Obstructive sleep apnea

When to use 7A41 versus 7A40: The code 7A41 should be used when polysomnography demonstrates that respiratory events are predominantly obstructive, characterized by the presence of persistent or increased thoracic and abdominal respiratory effort during airflow pauses. Clinically, patients with obstructive apnea frequently present with intense snoring, nocturnal gasping, obesity, and anatomical alterations of the upper airway.

Main difference: The fundamental distinction lies in the pathophysiological mechanism. In obstructive apnea (7A41), there is physical obstruction of the upper airway with maintenance of respiratory neural drive (the brain sends signals to breathe, but air does not pass). In central apnea (7A40), there is failure of respiratory neural drive (the brain does not adequately send signals to breathe), resulting in absence of respiratory effort. This difference is objectively identified by the respiratory effort sensors of polysomnography.

7A42: Sleep-related hypoxia or hypoventilation disorders

When to use 7A42 versus 7A40: The code 7A42 is appropriate for conditions where there is alveolar hypoventilation (sustained elevation of CO2) or hypoxemia during sleep, without episodic and recurrent central apneic events. Examples include obesity-related hypoventilation syndrome, hypoventilation from neuromuscular diseases, thoracic cage alterations, or congenital central alveolar hypoventilation.

Main difference: Central apnea (7A40) is characterized by discrete and recurrent respiratory events (apneas or hypopneas) with identifiable onset and offset, generally lasting 10-60 seconds each. Hypoventilation (7A42) manifests as sustained reduction in ventilation over prolonged periods of sleep, without necessarily presenting discrete apneic events. A patient may have continuous hypoventilation during REM sleep, for example, without recurrent central apneas, a situation in which 7A42 would be more appropriate.

Differential Diagnoses

Periodic breathing at altitude: May mimic central apnea, but is usually self-limited when the individual returns to lower altitudes. If persistent and symptomatic, it justifies coding with 7A40.

Hyperventilation syndrome: Respiratory pauses during wakefulness related to anxiety should not be confused with central sleep apnea. Polysomnography clearly differentiates these conditions.

Complex sleep apnea: Some authors use this term to describe emergent central apnea with treatment. It is appropriately coded with 7A40, and may also include 7A41 if there is significant baseline obstructive component.

Respiratory disorders in neuromuscular diseases: When there is respiratory muscle weakness causing hypoventilation without discrete central events, 7A42 is more appropriate. If there is impairment of central neural control of respiration with central apneas, 7A40 is correct.

8. Differences with ICD-10

In ICD-10, central sleep apneas were coded primarily with G47.3 (Sleep apneas), a code that encompassed both central and obstructive apneas without specific differentiation. Some systems used unofficial subcategories or additional codes to distinguish the types.

Main changes in ICD-11:

ICD-11 introduces explicit and clear differentiation between central apnea (7A40) and obstructive apnea (7A41), recognizing that these conditions have distinct pathophysiologies, diagnostic approaches, and treatments. This separation allows greater precision in coding and facilitates specific epidemiological studies.

ICD-11 also formally recognizes the possibility of coexistence of central and obstructive events in the same patient, allowing dual coding when clinically appropriate. This approach better reflects clinical reality, where many patients present mixed patterns.

The hierarchical structure of ICD-11 better organizes sleep-related respiratory disorders, creating distinct categories for apneas (7A40 and 7A41) and hypoventilation (7A42), while ICD-10 had less specificity in this differentiation.

Practical impact of these changes:

For healthcare professionals, ICD-11 offers greater diagnostic precision, facilitating communication between specialists and the selection of specific treatments. For researchers, it allows more accurate epidemiological studies on the prevalence and outcomes of central versus obstructive apneas. For health systems, it improves resource allocation and planning of specialized services. For patients, it potentially results in more precise diagnoses and more targeted treatments.

The transition from ICD-10 to ICD-11 requires training of coders and healthcare professionals to ensure correct application of the new codes and to fully take advantage of the benefits of greater diagnostic specificity.

9. Frequently Asked Questions

1. How is central sleep apnea diagnosed?

Definitive diagnosis requires polysomnography, an examination performed overnight in a sleep laboratory or, in some cases, at home with portable equipment. The examination records multiple parameters simultaneously: brain activity, eye movements, muscle tone, nasal and oral airflow, thoracic and abdominal respiratory effort, oxygen saturation, and heart rate. The absence of respiratory effort during airflow pauses characterizes the events as central. The sleep medicine specialist analyzes the complete study, quantifies the events, and determines whether there is a predominance of clinically significant central apneas.

2. Is treatment for central sleep apnea available in public health systems?

Availability varies according to the health system and geographic region. Many public health systems offer access to diagnostic polysomnography and sleep apnea treatments, although there may be waiting lists. Treatments for central apnea include optimization of underlying medical conditions (such as heart failure), non-invasive ventilation devices (such as adaptive servo-ventilation or BiPAP), supplemental oxygen therapy, and in specific cases, medications. Coverage of these treatments varies, and it is important to consult local health policies.

3. How long does treatment for central sleep apnea last?

Central sleep apnea generally requires long-term or indefinite treatment, especially when related to chronic conditions such as heart failure. Exceptions include medication-induced central apnea (which may resolve with medication adjustment or discontinuation), altitude-related apnea (which resolves upon returning to lower altitudes), and treatment-emergent central apnea (which may resolve spontaneously in some cases). Regular follow-up with a sleep medicine specialist is recommended to monitor treatment efficacy, adjust ventilation parameters, and evaluate the need for continued therapy.

4. Can this code be used in medical certificates and official documents?

Yes, the ICD-11 code 7A40 can and should be used in medical certificates, clinical reports, procedure requests, justifications for treatments, and other official documents when the diagnosis of central sleep apnea is confirmed by polysomnography. The inclusion of the code facilitates understanding of the diagnosis by other professionals, justifies absences when necessary (in severe cases with significant daytime sleepiness that compromises professional activities), and properly documents the need for specific treatments. It is advisable to also include information about severity and etiology when relevant.

5. Can central apnea coexist with obstructive apnea in the same patient?

Yes, it is relatively common for patients to present with both central and obstructive events. Polysomnography quantifies both types and determines which is predominant. When both are clinically significant, it is appropriate to use both codes (7A40 and 7A41), documenting the mixed nature of the sleep-related respiratory disorder. This situation is particularly common in patients with heart failure who also have obesity or anatomical airway alterations, and in cases of treatment-emergent central apnea, where there was initially obstructive apnea that developed a central component after initiation of positive pressure therapy.

6. What are the main risk factors for developing central sleep apnea?

The main risk factors include: congestive heart failure (especially with reduced ejection fraction), chronic opioid medication use, stroke or other central nervous system lesions, chronic kidney disease, atrial fibrillation, male sex, advanced age, exposure to high altitudes, and paradoxically, treatment of obstructive sleep apnea with positive pressure (treatment-emergent central apnea). Patients with multiple risk factors have a higher probability of developing central apnea and should be monitored appropriately.

7. How can central apnea be clinically differentiated from obstructive apnea before polysomnography?

Clinically, differentiation can be challenging, as many symptoms overlap (daytime sleepiness, fatigue, fragmented sleep). Some features suggest central apnea: presence of heart failure or neurological conditions, opioid use, absence of intense snoring, absence of significant obesity, awakenings with sensation of breathlessness (more common in central apnea, especially with Cheyne-Stokes). Features suggesting obstructive apnea: intense snoring, obesity, increased neck circumference, anatomical airway alterations, nocturnal choking. However, only polysomnography allows definitive diagnosis and objective differentiation.

8. What is treatment-emergent central apnea and how should it be coded?

Treatment-emergent central apnea occurs when a patient initially diagnosed with obstructive sleep apnea develops significant central apneas after initiation of continuous positive airway pressure (CPAP) therapy. This phenomenon occurs in a minority of patients and may be transient or persistent. When emergent central events are clinically significant and persist on subsequent polysomnographies, code 7A40 is appropriate. Some systems may opt for dual coding (7A40 and 7A41) to document both the baseline obstructive condition and the development of central events. Management may include adjustment of pressure parameters, switching to BiPAP or adaptive servo-ventilation, or observation, as some cases resolve spontaneously.

---

Conclusion

Proper coding of central sleep apnea using ICD-11 code 7A40 requires clear understanding of pathophysiology, objective diagnostic confirmation by polysomnography, and careful differentiation from other sleep-related respiratory conditions. Accuracy in coding not only facilitates documentation and clinical communication but also ensures that patients receive appropriate treatments for their specific condition, considering that therapeutic approaches for central apneas differ significantly from those used for obstructive apneas. Recognition of the possibility of mixed patterns and proper documentation of specific etiologies enriches diagnostic characterization and guides individualized therapeutic decisions.

External References

This article was prepared based on reliable scientific sources:

1. 🌍 WHO ICD-11 - Central sleep apneas
2. 🔬 PubMed Research on Central sleep apneas
3. 🌍 WHO Health Topics
4. 📊 Clinical Evidence: Central sleep apneas
5. 📋 Ministry of Health - Brazil
6. 📊 Cochrane Systematic Reviews

References verified on 2026-02-03